Multi-Drug Resistant TB (MDR-TB) Clinical Advice Service
key details
| Status | complete |
|---|---|
| Procedure | direct |
| OCID | ocds-h6vhtk-06cfbb |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| British Thoracic Society | · | · | active |
description
The MDR-TB Clinical Advice Service provides expert, consistent and safe advice to clinicians treating MDR-TB. The Clinical Advice Service examines and ratifies local MDR-TB centre requests for the use of the MDR-TB agents, Bedaquiline and Delamanid.
Due to delays arising from administrative and operational circumstances, NHS England awarded this contract to British Thoracic Society commencing 01.04.2026
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 21 Jul 2026 | Contract details (UK7) | Procurement Act 2023 | 068648-2026 |
more from NHS England
- Exam Support Packages for EoE GP Registrars · £72,673 · 24 Jul 2026
- Refer a Patient - Adult ECMO 2026/27 · £99,362 · 23 Jul 2026
- Higher Specialist Scientist Training Programme (HSST) · £42,186,231 · 23 Jul 2026
- Imaging National Lecture Series · £400,000 · 22 Jul 2026
- NHS National Framework for Lenvatinib · £35,833,000 · 22 Jul 2026
- The Practice Education Facilitator role in Return to Practice · £20,000 · 22 Jul 2026
- Pharmacy Technician Clinical Skills Development · £300,000 · 22 Jul 2026
- NHS National Framework for Ferric Carboxymaltose injection · £62,633,000 · 21 Jul 2026
all contracts from this buyer →
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.